Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid treatments

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 6, 2003, Pages 2030-2035

  Crémieux, Anne Claude ^b   Muller Serieys, Claudette ^a   Panhard, Xavière ^c   Delatour, Frédérique ^b   Tchimichkian, Marina ^d   Mentre, France ^c   Andremont, Antoine ^a,c  

^a EMI U 9933   (France)

^b Clinical Investigation Center 9201   (France)

^c BICHAT HOSPITAL   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; TELITHROMYCIN;

ADULT; AEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMMENSALISM; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; DRUG BLOOD LEVEL; FECES MICROFLORA; HUMAN; MALE; MICROFLORA; NONHUMAN; NORMAL HUMAN; OROPHARYNX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN; STREPTOCOCCUS; YEAST;

ADULT; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIA, AEROBIC; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FECES; HUMANS; KETOLIDES; MACROLIDES; MALE; OROPHARYNX; SKIN; YEASTS;

EID: 0038778639     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.6.2030-2035.2003     Document Type: Article

References (27)

1. Balfour, J. A., and D. P. Figgitt. 2001. Telithromycin. Drugs 61:815-831.
2. Balle, V. H., S. E. Stangerup, J. Sederberg-Olsen, J. Thomsen, and R. Vejlsgaard. 1990. Amoxicillin/clavulanate treatment in secretory otitis media. Bacteriological findings in the nasopharynx. Acta Otolaryngol. 110:274-278.
3. Bartlett, J. G. 2002. Clinical practice. Antibiotic-associated diarrhea. N. Engl J. Med. 346:334-339.
4. Brook, I., and A. E. Gober. 1998. Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media. J. Antimicrob. Chemother. 41:489-492.
5. Bryskier, A. 2000. Ketolides-telithromycin, an example of a new class of antibacterial agents. Clin. Microbiol. Infect. 6:661-669.
6. Comité de l'Antibiogramme de la Société Française de Microbiologie. February 2003, posting date. Communiqué du Comité de l'Antibiogramme de la Société Française de Microbioiogie. [Online.] http://www.sfm.asso.fr.
7. Doucet-Populaire, F., P. Trieu-Cuot, A. Andremont, and P. Courvalin. 1992. Conjugal transfer of plasmid DNA from Enterococcus faecalis to Escherichia coli in digestive tracts of gnotobiotic mice. Antimicrob. Agents Chemother. 36:502-504.
8. Doucet-Populaire, F., P. Trieu-Cuot, I. Dosbaa, A. Andremont, and P. Courvalin. 1991. Inducible transfer of conjugative transposon Tn1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice. Antimicrob. Agents Chemother. 35:185-187.
9. Edlund, C., G. Alvan, L. Barkholt, F. Vacheron, and C. E. Nord. 2000. Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora. J. Antimicrob. Chemother. 46:741-749.
10. Foulstone, M., and C. Reading. 1982. Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography. Antimicrob. Agents Chemother. 22:753-762.
11. Ghaffar, F., L. S. Muniz, K. Katz, J. L. Smith, T. Shouse, P. Davis, and G. H. McCracken, Jr. 2002. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. Clin. Infect. Dis. 34:1301-1309.
12. Hofstra, W., G. W. Welling, and D. Van der Waaij. 1988. A comparative study of the effect of oral treatment with augmentin, amoxycillin and bacampicillin on the faecal flora in mice. Zentbl. Bakteriol. Mikrobiol. Hyg. A 269:78-85.
13. Janoir, C., I. Podglajen, M. Kitzis, C. Poyart, and L. Gutmann. 1999. In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis. J. Infect. Dis. 180:555-558.
14. Leclercq, R. 2001. Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin. J. Antimicrob. Chemother. 48(Suppl. T1):9-23.
15. Lester, S., M. Del Pilar Pla, F. Wang, I. Perez Schaeli, and T. O'Brien. 1990. The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, Caracas, Venezuela, and in Qin Pu, China. N. Engl. J. Med. 323:285-289.
16. Murray, B. E., E. R. Rensimer, and H. L. DuPont. 1982. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N. Engl. J. Med. 306:130-135.
17. Neu, H. C., A. P. Wilson, and R. N. Gruneberg. 1993. Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992. J. Chemother. 5:67-93.
18. Noble, W. C., Z. Virani, and R. G. Cree. 1992. Co-transfer ofvancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 72:195-198.
19. Samonis, G., A. Gikas, P. Toloudis, S. Maraki, G. Vrentzos, Y. Tselentis, N. Tsaparas, and G. Bodey. 1994. Prospective study of the impact of broadspectrum antibiotics on the yeast flora of the human gut. Eur. J. Clin. Microbiol. Infect. Dis. 13:665-667.
20. Scanvic-Hameg, A., E. Chachaty, J. Rey, C. Pousson, M. Ozoux, E. Brunel, and A. Andremont. 2002. Impact of quinupristin/dalfopristin (RP 59500) on the faecal microflora in healthy volunteers. J. Antimicrob. Chemother. 49:135-139.
21. Simes, R. 1986. An improved Bonferroni procedure for multiple tests of significance. Biometrika 73:751-754.
22. Smith, G. E., M. R. Fulford, R. W. Matthews, and D. C. Speller. 1989. Roxithromycin as a possible agent for prophylaxis of endocarditis: a study in normal volunteers. J. Antimicrob. Chemother. 23:417-425.
23. Sullivan, A., C. Edlund, and C. E. Nord. 2001. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 1:101-114.
24. Terpstra, S., G. T. Noordhoek, H. G. Voesten, B. Hendriks, and J. E. Degener. 1999. Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. J. Hosp. Infect. 43:195-202.
25. Varon, E., and L. Gutmann. 2000. Mechanisms and spread of fluoroquinolone resistance in Streptococcus pneumoniae. Res. Microbiol. 151:471-473.
26. Vlaspolder, F., G. de Zeeuw, M. Rozenberg-Arska, P. Egyedi, and J. Verhoef. 1987. The influence of flucloxacillin and amoxicillin with clavulanic acid on the aerobic flora of the alimentary tract. Infection 15:241-244.
27. Wu, S. W., H. de Lencastre, and A. Tomasz. 2001. Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus. J. Bacteriol. 183:2417-2424.